How are CRMD long call max profit and max loss calculated?

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the CRMD long call priced from the end-of-day chain at a 30-day expiry (ATM IV 237.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$80.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a CRMD long call?

The breakeven for the CRMD long call priced on this page is roughly $8.80 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CRMD market-implied 1-standard-deviation expected move is approximately 68.18%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current CRMD implied volatility affect this long call?

CRMD ATM IV is at 237.80% with IV rank near 79.42%, which is elevated relative to its 1-year range. Premium-selling structures (covered call, cash-secured put, iron condor) generally look more attractive when IV rank is high; premium-buying structures (long call, long put, debit spreads) are more expensive in that regime.

CRMD Long Call Strategy

CRMD (CorMedix Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving markets both in the United States and internationally. Its leading product candidate, DefenCath/Neutrolin, represents a novel anti-infective solution. This treatment aims to diminish and avert catheter-related infections and blood clots in patients who utilize central venous catheters for medical procedures such as hemodialysis, total parenteral nutrition, and oncology care. Incorporated in 2006, the company initially operated as Picton Holding Company, Inc. until officially adopting the name CorMedix Inc. in January 2007. Its corporate headquarters are located in Berkeley Heights, New Jersey.

CRMD (CorMedix Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $615.8M, a trailing P/E of 3.45, a beta of 1.47 versus the broader market, a 52-week range of 6.13-14.96, average daily share volume of 1.3M, a public-listing history dating back to 2010, approximately 64 full-time employees. These structural characteristics shape how CRMD stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.47 indicates CRMD has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. The trailing P/E of 3.45 is on the value side, where IV often compresses outside event windows because forward growth expectations are already discounted into the share price.

What is a long call on CRMD?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current CRMD snapshot

As of June 30, 2026, spot at $7.81, ATM IV 237.80%, IV rank 79.42%, expected move 68.18%. The long call on CRMD below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 52-day expiry.

Why this long call structure on CRMD specifically: CRMD IV at 237.80% is rich versus its 1-year range, which makes a premium-buying CRMD long call relatively expensive in absolute-cost terms, with a market-implied 1-standard-deviation move of approximately 68.18% (roughly $5.32 on the underlying). The 52-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CRMD expiries trade a higher absolute premium for lower per-day decay. Position sizing on CRMD should anchor to the underlying notional of $7.81 per share and to the trader's directional view on CRMD stock.

CRMD long call setup

The CRMD long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CRMD near $7.81, the first option leg uses a $8.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CRMD chain at a 52-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CRMD shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$8.00	$0.80

CRMD long call risk and reward

Net Premium / Debit: -$80.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$80.00
Breakeven(s): $8.80
Risk / Reward Ratio: Unbounded

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

CRMD long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on CRMD. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-99.9%	-$80.00
$1.74	-77.8%	-$80.00
$3.46	-55.7%	-$80.00
$5.19	-33.6%	-$80.00
$6.91	-11.5%	-$80.00
$8.64	+10.6%	-$16.14
$10.36	+32.7%	+$156.44
$12.09	+54.8%	+$329.01
$13.82	+76.9%	+$501.58
$15.54	+99.0%	+$674.16

When traders use long call on CRMD

Long calls on CRMD express a bullish thesis with defined risk; traders use them ahead of CRMD catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

CRMD thesis for this long call

The market-implied 1-standard-deviation range for CRMD extends from approximately $2.49 on the downside to $13.13 on the upside. A CRMD long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current CRMD IV rank near 79.42% sits in the upper third of its 1-year distribution, which historically reverts; this raises the bar for premium-buying structures and lowers it for premium-selling structures on CRMD at 237.80%. As a Healthcare name, CRMD options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CRMD-specific events.

CRMD long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CRMD positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CRMD alongside the broader basket even when CRMD-specific fundamentals are unchanged. Long-premium structures like a long call on CRMD are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current CRMD chain quotes before placing a trade.

Frequently asked questions

What is a long call on CRMD?: A long call on CRMD is the long call strategy applied to CRMD (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With CRMD stock trading near $7.81, the strikes shown on this page are snapped to the nearest listed CRMD chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are CRMD long call max profit and max loss calculated?: Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the CRMD long call priced from the end-of-day chain at a 30-day expiry (ATM IV 237.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$80.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a CRMD long call?: The breakeven for the CRMD long call priced on this page is roughly $8.80 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CRMD market-implied 1-standard-deviation expected move is approximately 68.18%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on CRMD?: Long calls on CRMD express a bullish thesis with defined risk; traders use them ahead of CRMD catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current CRMD implied volatility affect this long call?: CRMD ATM IV is at 237.80% with IV rank near 79.42%, which is elevated relative to its 1-year range. Premium-selling structures (covered call, cash-secured put, iron condor) generally look more attractive when IV rank is high; premium-buying structures (long call, long put, debit spreads) are more expensive in that regime.